Published in J Pineal Res on August 01, 2007
Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer (2008) 1.18
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones. Free Radic Biol Med (2008) 1.10
Peripheral reproductive organ health and melatonin: ready for prime time. Int J Mol Sci (2013) 0.84
Posttranscriptional regulation of pineal melatonin synthesis in Octodon degus. J Pineal Res (2009) 0.81
Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells. Asian J Androl (2009) 0.81
Melatonin as an adjuvant to therapeutic prostate cancer vaccines. J Pineal Res (2008) 0.80
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis. Int J Mol Sci (2017) 0.75
Expression and putative functions of melatonin receptors in malignant cells and tissues. Wien Med Wochenschr (2014) 0.75
Melatonin and Hippo Pathway: Is There Existing Cross-Talk? Int J Mol Sci (2017) 0.75
Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype. J Pineal Res (2003) 1.02
Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Gα(s) and Gα(q) proteins. J Pineal Res (2010) 0.79
Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug? J Pineal Res (2003) 0.78